Aims: To identify the risk factors of posterior iris synechia formation after phacovitrectomy with posterior chamber single-piece acrylic intraocular lens (IOL; Acrysof® SA60AT) or 3-piece acrylic IOL (Acrysof® MA60BM) implantation. Methods: We selected 153 eyes of 153 patients treated by phacovitrectomy between March 2000 and August 2006 and retrospectively reviewed the relationship between iris posterior synechiae and various factors, such as IOL type, tamponade, preoperative iris posterior synechiae, major indications for surgery, axial length and preoperative anterior chamber (AC) depth. Results: IOL type (p = 0.0447), C3F8 gas tamponades (p = 0.0074), preoperative iris posterior synechiae (p = 0.0001) and postoperative AC fibrin deposition (p = 0.0303) were significantly associated with postoperative iris posterior synechiae by multiple logistic regression analysis. The odds ratio (OR) for single-piece IOL versus 3-piece IOL was 2.658 (95% confidence interval, CI: 1.010–6.993), the OR for C3F8 gas versus balanced salt solution was 4.051 (95% CI: 1.455–11.281), for the presence of preoperative iris posterior synechiae 12.868 (95% CI: 3.511–47.165), and the OR for postoperative AC fibrin deposition was 6.012 (95% CI: 1.186–30.468). Conclusion: Preoperative iris posterior synechiae, C3F8 gas tamponade, postoperative AC fibrin deposition and the single-piece IOL could increase the rates of iris posterior synechiae after phacovitrectomy.

1.
Heiligenhaus A, Holtkamp A, Koch J, Schilling H, Bornfeld N, Lösche CC, Steuhl KP: Combined phacoemulsification and pars plana vitrectomy: clear corneal versus scleral incisions: prospective randomized multicenter study. J Cataract Refract Surg 2003;29:1106–1112.
2.
Honjo M, Ogura Y: Surgical results of pars plana vitrectomy combined with phacoemulsification and intraocular lens implantation for complications of proliferative diabetic retinopathy. Ophthalmic Surg Lasers 1998;29:99–105.
3.
Lahey JM, Francis RR, Kearney JJ: Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology 2003;110:1335–1339.
4.
Senn P, Schipper I, Perren B: Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a two-step procedure. Ophthalmic Surg Lasers 1995;26:420–428.
5.
Ogino N, Uchida H: Combined pars plana vitrectomy, lens removal and intraocular lens implantation for complications of diabetic retinopathy: surgical results in 120 cases. Nippon Ganka Gakkai Zasshi 1994;98:672–678.
6.
Shinoda K, O’hira A, Ishida S, Hoshide M, Ogawa LS, Ozawa Y, Nagasaki K, Inoue M, Katsura H: Posterior synechia of the iris after combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation. Jpn J Ophthalmol 2001;45:276–280.
7.
Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT; Global Diabetic Retinopathy Project Group: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677–1682.
8.
Lahey JM, Francis RR, Fong DS, Kearney JJ, Tanaka S: Combining phacoemulsification with vitrectomy for treatment of macular holes. Br J Ophthalmol 2002;86:876–878.
9.
Holland GN, Van Horn SD, Margolis TP: Cataract surgery with ciliary sulcus fixation of intraocular lenses in patients with uveitis. Am J Ophthalmol 1999;128:21–30.
10.
McDonnell PJ, Zarbin MA, Green WR: Posterior capsule opacification in pseudophakic eyes. Ophthalmology 1983;90:1548–1553.
11.
Yeo JH, Jakobiec FA, Pokorny K, Iwamoto T, Pisacano A: The ultrastructure of an IOL ‘cocoon membrane’. Ophthalmology 1983;90:410–419.
12.
Hanemoto T, Ideta H, Kawasaki T, Ideta R, Okuyama M: Suture fixation of an intraocular lens combined with pars plana vitrectomy and gas tamponade. J Cataract Refract Surg 2003;29:2458–2460.
13.
Iwase T, Sugiyama K: Investigation of the stability of one-piece acrylic intraocular lenses in cataract surgery and in combined vitrectomy surgery. Br J Ophthalmol 2006;90:1519–1523.
14.
Foster RE, Lowder CY, Meisler DM, Zakov ZN: Extracapsular cataract extraction and posterior chamber intraocular lens implantation in uveitis patients. Ophthalmology 1992;99:1234–1241.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.